Regulating Cathelicidin Expression for Disease Therapy

调节导管素表达以治疗疾病

• 批准号: 7700943
• 负责人: Adrian Friedrich Gombart
• 金额: $ 26.45万
• 依托单位: OREGON STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-15 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7700943
• 关键词: Achievement; Antibiotic Resistance; Atopic Dermatitis; Automobile Driving; Bacteria; Binding; Biological; CCAAT-Enhancer-Binding Proteins; Cebidae; Cholecalciferol; Clinical; Defensins; Development; Disease; Epithelial; Epithelial Cells; Family; Gene Expression; Gene Expression Regulation; Genes; Genetic; Genetic Transcription; Goals; Health; Hematopoietic; Host Defense; Human; Immune; In Vitro; Infection; Inflammation; Investigation; Knowledge; Lead; Localized; Mammals; Mediating; Microbe; Molecular; Myelogenous; Pharmaceutical Preparations; Primates; Process; Prosimii; Regulation; Research; Retinoids; Sepsis; Signal Pathway; Steroids; Testing; Therapeutic; Therapeutic Uses; Thyroid Hormone Receptor; Tissues; Transcriptional Regulation; Transgenic Mice; Vitamin D; Vitamins; antimicrobial; antimicrobial peptide; antimicrobial peptide LL-37; cathelicidin; cell type; driving force; human disease; in vivo; in vivo Model; insight; interest; microbial; mouse model; neutrophil; novel; pathogen; promoter; response; small molecule; transcription factor

DESCRIPTION (provided by applicant): Infections by antibiotic resistant bacteria and the potential for sepsis are a major health concern. Antimicrobial peptides (AMPs) like cathelicidins (CAMP) and defensins are generating considerable interest for therapeutic use as potential bactericidals, anti-LPS drugs and modulators of inflammation, and other potential uses. However, the mechanisms governing CAMP expression are largely unknown. The central hypothesis driving the proposed research is that transcription factors (TFs) from the CCAAT/enhancer binding protein (C/EBP), ETS/PU.1, CREB/ATF and the steroid/thyroid hormone receptor families control constitutive and inducible expression of CAMP in hematopoietic and epithelial tissues. We propose an investigation directed towards achieving 3 Specific Aims: [1] Identify the TFs in myeloid and epithelial cells that regulate CAMP gene transcription; [2a] Determine extent of vitamin DS-mediated induction of CAMP in various human cell types and atopic dermatitis; [2b] Identify mechanism of synergistic activation of human CAMP gene expression by retinoids and vitamin D3; [2c] Discover novel small molecules that regulate CAMP gene expression; [3] Elucidate the biological importance and potential therapeutic benefits of vitamin D3 regulation of CAMP gene expression. Specific Aims 1 and 2 will generate a comprehensive assessment of the transcriptional regulation of the CAMP gene in the myeloid and epithelial compartments and identify additional compounds that either alone or in combination with vitamin D3 may prove therapeutically useful. Specific Aim 3 will characterize the evolutionary and biological importance of antimicrobial gene regulation by vitamin D and will use parallel in vitro and in vivo mouse models that exploit a powerful genetic approach to critically examine how vitamin D3 regulates expression of CAMP in response to microbial invasion or challenge with pathogen-derived molecules. Achievement of these specific aims will provide a comprehensive knowledge of the transcriptional regulation of the CAMP gene and demonstrate the biological importance of vitamin D3-mediated regulation of antimicrobial peptides. This knowledge will lead to the development of approaches for extrinsically manipulating endogenous CAMP expression for systemic and localized therapeutic benefit of human diseases.

描述（由申请人提供）：抗生素耐药细菌感染和潜在败血症是主要的健康问题。抗菌肽（AMPs），如抗菌肽（CAMP）和防御素，作为潜在的杀菌剂、抗脂多糖药物和炎症调节剂以及其他潜在用途，正在引起人们的极大兴趣。然而，控制CAMP表达的机制在很大程度上是未知的。驱动该研究的中心假设是CCAAT/增强子结合蛋白（C/EBP）， ETS/PU的转录因子（TFs）。1、CREB/ATF和类固醇/甲状腺激素受体家族控制造血和上皮组织CAMP的组成性和诱导性表达。我们提出了一项针对实现3个特定目标的研究：b[1]鉴定髓细胞和上皮细胞中调节CAMP基因转录的tf；[2a]维生素ds介导的CAMP在人不同细胞类型和特应性皮炎中的诱导程度；[2b]类维生素a和维生素D3协同激活人CAMP基因表达的机制；[2]发现CAMP基因表达调控的新分子；阐明维生素D3调节CAMP基因表达的生物学重要性和潜在的治疗益处。具体目标1和2将对髓细胞和上皮细胞间室CAMP基因的转录调控进行全面评估，并确定单独或与维生素D3联合可能被证明具有治疗作用的其他化合物。Specific Aim 3将描述维生素D调控抗菌基因的进化和生物学重要性，并将使用平行的体外和体内小鼠模型，利用强大的遗传方法来严格检查维生素D3如何调节CAMP的表达，以应对微生物入侵或病原体来源分子的挑战。这些特定目标的实现将提供CAMP基因转录调控的全面知识，并证明维生素d3介导的抗菌肽调控的生物学重要性。这一知识将导致外部操纵内源性CAMP表达的方法的发展，以实现人类疾病的全身和局部治疗益处。